IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year

{
  "signal_id": "d6c9ea9d-5ce9-e8b1-4e0f-779f2dba62ba",
  "signal_type": "news",
  "signal_subtype": "receives_award",
  "detected_at": "2026-08-20T20:15:00+00:00",
  "company": {
    "name": "IQVIA",
    "domain": "iqvia.com"
  },
  "data": {
    "url": "https://sg.finance.yahoo.com/news/iqvias-ai-enabled-clinical-decision-201500451.html",
    "award": "2026 AI Breakthrough Award for Predictive Modeling Solution of the Year",
    "title": "IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year - Yahoo Finance Singapore",
    "excerpt": "RESEARCH TRIANGLE PARK, N.C., August 20, 2026 --( BUSINESS WIRE )-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that its AI-enabled Clinical Decision Support Tool, developed in collaboration with Breakthrough T1D, has won the 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year. Powered by IQVIA Healthcare-grade AI®, the tool tackles a long-standing problem in diabetes care: adults with type 1 diabetes (T1D) are often misclassified as having type 2 diabetes (T2D). That mistake delays the right treatment and raises the risk of serious, sometimes life-threatening complications. Results in practice: Cut the screening workload by 99.5%, narrowing reviews from about 60,000 patients down to 300, or roughly 200 times fewer chart reviews. Delivered a ~127x increase in diagnostic yield - 28% of flagged patients were confirmed or suspected to have T1D, versus a 0.22% baseline. Accelerated the path to the right diagnosis and treatment, helping reduce the risk of complications and improving long-term outcomes. The Clinical Decision Support Tool was configured in partnership with Breakthrough T1D, the leading global T1D research and advocacy non-profit organization, to enable healthcare providers to close persistent gaps in care...",
    "product": "AI-enabled Clinical Decision Support Tool",
    "summary": "IQVIA's AI-enabled Clinical Decision Support Tool won the 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year.",
    "location": "Research Triangle Park, NC, USA",
    "planning": false,
    "image_url": "https://s.yimg.com/lo/mysterio/api/55EC40939762485002795778FC1A3DD318331BD6E4B3283901676056E2975EE3/subgraphmysterio/resizefill_w1200_h459;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fbusiness-wire.com%2F0cb80fccf5dc32470d2611db146013c4.jpg",
    "confidence": 0.95,
    "product_data": {
      "name": "AI-enabled Clinical Decision Support Tool",
      "full_text": "AI-enabled Clinical Decision Support Tool",
      "fuzzy_match": false
    },
    "product_tags": [
      "future_tech",
      "medical",
      "data"
    ],
    "published_at": "2026-08-20T20:15:00Z",
    "location_data": [
      {
        "city": "Research Triangle Park",
        "state": "North Carolina",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-08-20",
    "article_sentence": "IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that its AI-enabled Clinical Decision Support Tool, developed in collaboration with Breakthrough T1D, has won the 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year."
  }
}

curl https://signals.autobound.ai/v1/signals/d6c9ea9d-5ce9-e8b1-4e0f-779f2dba62ba \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"iqvia.com","limit":20}'